All In MedTech

Device Trial Radar · NCT03247439

Safety and Effectiveness of Cartiva Implant in the Treatment of First CMC Joint Osteoarthritis Compared to LRTI (GRIP 2)

A Prospective Study to Evaluate the Safety and Effectiveness of the Cartiva® Synthetic Cartilage Implant for CMC in the Treatment of First Carpometacarpal Joint Osteoarthritis as Compared to a Ligament Reconstruction Tendon Interposition (LRTI) Comparator

Last checked: Nov 20, 2026Latest source record: Dec 3, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

74

Actual

Start

Dec 22, 2017

Primary completion

Oct 30, 2020

Study completion Mar 2024

Sponsor

Lead sponsor
Cartiva, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Aug 11, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate whether Cartiva is an effective treatment for individuals with osteoarthritis of the first CMC joint in the hand compared to LRTI.

Conditions

  • Osteoarthritis

Interventions

  • CartivaDevice

    Synthetic Cartilage Implant

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pain measured by the Visual Analog Scale (VAS) scaleTime frame: 1 year
  2. Function measured by QuickDASHTime frame: 1 year
  3. Radiographic FindingsTime frame: 1 year

1 more outcomes with a free account

Locations

9 sites in 2 countries. Site status is shown where the registry gives one.

  • University of California, San Diego

    San Diego, California

  • Georgia Hand, Shoulder & Elbow

    Atlanta, Georgia

  • Indiana Hand to Shoulder Center

    Indianapolis, Indiana

6 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.